Source: DGNews  |  Posted 8 years ago

First ever trial into treatment of newly-defined disease subtype

PARIS, FRANCE -- June 9, 2003 -- New data presented at the 22nd European Academy of Allergology and Clinical Immunology (EAACI), 7 - 11 June 2003, in Paris, France, today show that Xyzal